E-LIB Suche - Ergebnisse für: Wild, G.

1

P412 Faecal Calprotectin as a predictor of endoscopic and h..:

Drügg Hahn, G ; Flores, C ; Afif, W...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i851-i852 , 2024

2

A259 METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEA..:

Kablawi, D ; Sasson, S ; Aljohani, F...
Journal of the Canadian Association of Gastroenterology. 7 (2024) Supplement_1 - p. 208-209 , 2024

Link: https://doi.org/10.1093/..

3

P716 Efficacy and safety of upadacitinib during induction i..:

Jairath, R ; Zoughlami, A ; Pilote, N...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1347-i1347 , 2024

Link: https://doi.org/10.1093/..

4

P306 Rectal bleeding and stool frequency are strong predict..:

Alenezi, T ; Almushir, S ; Afif, W...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i685-i685 , 2024

Link: https://doi.org/10.1093/..

5

Numerical modelling of Lamb wave propagation in 2D plate st..:

Pollock, L. ; Wild, G.
The Aeronautical Journal. 127 (2023) 1318 - p. 2187-2203 , 2023

Link: https://doi.org/10.1017/..

6

A191 NONALCOHOLIC FATTY LIVER DISEASE AND LIVER FIBROSIS IN..:

Kablawi, D ; Aljohani, F ; Palumbo, C S...
Journal of the Canadian Association of Gastroenterology. 6 (2023) Supplement_1 - p. 36-37 , 2023

Link: https://doi.org/10.1093/..

7

A34 NONALCOHOLIC FATTY LIVER DISEASE AND LIVER FIBROSIS INC..:

Kablawi, D ; Aljohani, F ; Palumbo, C S...
Journal of the Canadian Association of Gastroenterology. 6 (2023) Supplement_1 - p. 18-19 , 2023

Link: https://doi.org/10.1093/..

8

P417 Frequent Early Nocebo Complaints but Maintained Clinic..:

Wetwittayakhlang, P ; Karkout, K ; Tselekouni, P...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i546-i546 , 2023

Link: https://doi.org/10.1093/..

9

A150 ASSOCIATION BETWEEN SERUM USTEKINUMAB CONCENTRATIONS A..:

Yanofsky, R ; Abduallah, Y ; Golovics, P...
Journal of the Canadian Association of Gastroenterology. 5 (2022) Supplement_1 - p. 24-25 , 2022

Link: https://doi.org/10.1093/..

10

A143 SAFETY OF BIOLOGICAL THERAPIES IN ELDERLY IBD: A SYSTE..:

Golovics, P ; Drügg Hahn, G ; Wetwittayakhlang, P...
Journal of the Canadian Association of Gastroenterology. 5 (2022) Supplement_1 - p. 16-17 , 2022

Link: https://doi.org/10.1093/..

11

A180 CLINICAL OUTCOMES OF COVID-19 AND IMPACT ON DISEASE CO..:

Wetwittayakhlang, P ; Albader, F ; Golovics, P...
Journal of the Canadian Association of Gastroenterology. 5 (2022) Supplement_1 - p. 61-63 , 2022

Link: https://doi.org/10.1093/..

12

P321 Mucosal Healing and Clinical remission after Treatment..:

Wetwittayakhlang, P ; Golovics, P ; Hahn, G...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i343-i345 , 2022

Link: https://doi.org/10.1093/..

13

DOP25 Clinical outcomes of COVID-19 and Impact on Disease C..:

Wetwittayakhlang, P ; Albader, F ; Golovics, P...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i077-i078 , 2022

Link: https://doi.org/10.1093/..

14

P582 Association between serum ustekinumab concentrations a..:

Yanofsky, R ; Abduallah, Y ; Golovics, P...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i522-i522 , 2022

Link: https://doi.org/10.1093/..

15

P318 Safety of Biological Therapies in Elderly IBD: a Syste..:

Drügg Hahn, G ; Golovics, P ; Wetwittayakhlang, P...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i341-i342 , 2022

Link: https://doi.org/10.1093/..